M. Plana

Stat1 implication in the immune response to superantigens in vivo.

J. Rodríguez-Sánchez, C. Juárez, J. Codony-Servat, 1996, Journal of immunology.

Safety and Immunogenicity of a Recombinant Protein RBD Fusion Heterodimer Vaccine against SARS-CoV-2: preliminary results of a phase 1-2a dose-escalating, randomized, double-blind clinical trial.

J. Blanco, B. Trinité, L. Leal, 2022, medRxiv.

Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy

L. Kuhn, S. Crovella, L. Zupin, 2016, Immunologic Research.

Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy

Felipe García, L. Kuhn, S. Crovella, 2016, Immunologic research.

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

A. Borobia, B. Clotet, J. Prado, 2022, The Lancet Regional Health - Europe.